January 15th 2021
Fellow Ken Takahashi, informs the Fellows of the Collegium Ramazzini that the Asbestos Diseases Research Institute (ADRI) in Australia just received the official WHO Designation as the WHO Collaborating Center for Elimination of Asbestos-Related Diseases (AUS-152).
its inception in 2009, ADRI has aimed to improve the diagnosis and treatment of
asbestos-related diseases and at the same time to contribute to more effective
measures to prevent exposure to asbestos. The institutional objectives include
amongst others; the sharing of preventive technologies to ban/abate asbestos,
the elimination/reduction of asbestos-related diseases and the transition to an
asbestos-free society – values that are much in line the WHO mandate on
To date, ADRI has already
demonstrated leadership and innovation in public health advocacy, data sharing,
training, capacity-building and technical advice on asbestos-related diseases
and has already conducted two successful international workshops in the
Philippines and Fiji in 2019 as well as a range of consultancies in preceding
years. I am delighted to state that this work, with its primary focus on
regional collaboration, will continue to grow stronger under the auspices of
and collaboration with the WHO. Please accept my sincere gratitude for your
continued recognition and support to ADRI as we take on another level of
The General Secretariat of the Collegium is located in the Castle of Bentivoglio, near Bologna.
For any inquiries write us a message.
All fields required.
Join the Collegium Ramazzini 2023 Conference
Bologna, from 22 to 25 October 2023LEARN MORE